Identification of the primary gene defect at the cytochrome P450 CYP2D locus
- PMID: 1978251
- DOI: 10.1038/347773a0
Identification of the primary gene defect at the cytochrome P450 CYP2D locus
Abstract
The mammalian cytochrome P450-dependent monooxygenase system is involved in the metabolism of drugs and chemical carcinogens. The role of these enzymes in toxicological response is exemplified by an autosomal recessive polymorphism at the cytochrome P450 CYP2D6 debrisoquine hydroxylase locus which results in the severely compromised metabolism of at least 25 drugs, and which in some cases can lead to life-threatening side-effects. In addition, this polymorphism, which affects 8-10% of the caucasian population, has been associated with altered susceptibility to lung and bladder cancer. Here we report the identification of the primary mutation responsible for this metabolic defect and the development of a simple DNA-based genetic assay to allow both the identification of most individuals at risk of drug side-effects and clarification of the conflicting reports on the association of this polymorphism with cancer susceptibility.
Similar articles
-
Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals.IARC Sci Publ. 1991;(115):281-7. IARC Sci Publ. 1991. PMID: 1820342
-
Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.Pharmacogenetics. 1993 Jun;3(3):123-30. Pharmacogenetics. 1993. PMID: 8101460
-
Dinucleotide repeat polymorphism at the human debrisoquine 4-hydroxylase (CYP2D) locus.Nucleic Acids Res. 1991 Apr 25;19(8):1961. Nucleic Acids Res. 1991. PMID: 2030982 Free PMC article. No abstract available.
-
Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer risk.Cancer Cells. 1991 Mar;3(3):93-6. Cancer Cells. 1991. PMID: 2054261 Review. No abstract available.
-
[Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies].Med Lav. 1992 Nov-Dec;83(6):557-75. Med Lav. 1992. PMID: 1296137 Review. Italian.
Cited by
-
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.Biochem J. 1992 Jan 15;281 ( Pt 2)(Pt 2):359-68. doi: 10.1042/bj2810359. Biochem J. 1992. PMID: 1736885 Free PMC article.
-
An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.Br J Clin Pharmacol. 1995 Oct;40(4):361-7. doi: 10.1111/j.1365-2125.1995.tb04558.x. Br J Clin Pharmacol. 1995. PMID: 8554938 Free PMC article.
-
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer.Front Cell Dev Biol. 2020 Dec 7;8:529386. doi: 10.3389/fcell.2020.529386. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33365308 Free PMC article.
-
Clinically relevant genetic variations in drug metabolizing enzymes.Curr Drug Metab. 2011 Jun;12(5):487-97. doi: 10.2174/138920011795495321. Curr Drug Metab. 2011. PMID: 21453273 Free PMC article. Review.
-
New nucleotide sequence data on the EMBL File Server.Nucleic Acids Res. 1991 Jun 25;19(12):3467-82. doi: 10.1093/nar/19.12.3467. Nucleic Acids Res. 1991. PMID: 2062670 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases